应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02269 药明生物
休市中 04-19 16:08:35
12.620
-0.620
-4.68%
最高
13.160
最低
12.500
成交量
4,929万
今开
13.120
昨收
13.240
日振幅
4.98%
总市值
537.50亿
流通市值
537.50亿
总股本
42.59亿
成交额
6.27亿
换手率
1.16%
流通股本
42.59亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
易方达张坤最新持仓动向曝光:减持药明生物,买入山西汾酒,还买了光刻机巨头
每日经济新闻 · 22分钟前
易方达张坤最新持仓动向曝光:减持药明生物,买入山西汾酒,还买了光刻机巨头
药明生物(02269.HK)4月19日耗资1992万港元回购157万股
格隆汇资讯 · 04-19 21:16
药明生物(02269.HK)4月19日耗资1992万港元回购157万股
药明生物(02269)4月19日斥资1992.04万港元回购157万股
智通财经 · 04-19 21:16
药明生物(02269)4月19日斥资1992.04万港元回购157万股
药明生物04月19日遭主力抛售7175万元 环比增加2149.22%
自选股智能写手 · 04-19 16:15
药明生物04月19日遭主力抛售7175万元 环比增加2149.22%
药明生物(02269)出现大手卖出54.95万股,成交价$12.66,涉资695.667万
阿斯达克财经 · 04-19 14:00
药明生物(02269)出现大手卖出54.95万股,成交价$12.66,涉资695.667万
医药外包概念集体走低 泰格医药(03347)跌超7% 机构称国内医药投融资仍阶段性承压
金吾财讯 · 04-19 10:49
医药外包概念集体走低 泰格医药(03347)跌超7% 机构称国内医药投融资仍阶段性承压
药明生物(02269.HK)回购151万股 涉资1,989万元
阿斯达克财经 · 04-17
药明生物(02269.HK)回购151万股 涉资1,989万元
药明生物(02269)4月16日斥资1989.32万港元回购151万股
智通财经 · 04-16
药明生物(02269)4月16日斥资1989.32万港元回购151万股
药明生物(02269)股价下跌5.007%,现价港币$12.9
阿斯达克财经 · 04-16
药明生物(02269)股价下跌5.007%,现价港币$12.9
药明生物(02269)出现大手卖出51.25万股,成交价$13.38,涉资685.725万
阿斯达克财经 · 04-16
药明生物(02269)出现大手卖出51.25万股,成交价$13.38,涉资685.725万
药明生物04月15日遭主力抛售1862万元 环比增加160.78%
自选股智能写手 · 04-15
药明生物04月15日遭主力抛售1862万元 环比增加160.78%
无锡药明生物技术股份有限公司药品申请临床试验默示许可获受理
金融界 · 04-15
无锡药明生物技术股份有限公司药品申请临床试验默示许可获受理
药明生物4月11日斥资1990.2万港元回购141.5万股
新浪港股 · 04-12
药明生物4月11日斥资1990.2万港元回购141.5万股
更新版 1-富士胶片将在北卡罗来纳州投资 12 亿美元扩建生物制药工厂
Reuters · 04-12
更新版 1-富士胶片将在北卡罗来纳州投资 12 亿美元扩建生物制药工厂
药明生物(02269.HK)回购141.5万股 涉资1,990万元
阿斯达克财经 · 04-11
药明生物(02269.HK)回购141.5万股 涉资1,990万元
药明生物(02269.HK)4月11日耗资1990.2万港元回购141.5万股
港股那点事 · 04-11
药明生物(02269.HK)4月11日耗资1990.2万港元回购141.5万股
药明生物(02269)4月11日斥资1990.2万港元回购141.5万股
智通财经网 · 04-11
药明生物(02269)4月11日斥资1990.2万港元回购141.5万股
药明生物(02269)下跌2.09%,报14.04元/股
金融界 · 04-11
药明生物(02269)下跌2.09%,报14.04元/股
药明生物(02269)出现大手买入44.2万股,成交价$14.3,涉资632.06万
阿斯达克财经 · 04-10
药明生物(02269)出现大手买入44.2万股,成交价$14.3,涉资632.06万
药明生物(02269)上涨2.08%,报14.7元/股
金融界 · 04-10
药明生物(02269)上涨2.08%,报14.7元/股
暂无数据
公司概况
公司名称:
药明生物
所属市场:
SEHK
上市日期:
--
主营业务:
药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"药明生物","latestPrice":12.62,"timestamp":1713514115032,"preClose":13.24,"halted":0,"volume":49290531,"delay":0,"floatShares":4259139569,"shares":4259139569,"eps":0.88178533,"marketStatus":"休市中","marketStatusCode":7,"change":-0.62,"latestTime":"04-19 16:08:35","open":13.12,"high":13.16,"low":12.5,"amount":627322028,"amplitude":0.049849,"askPrice":12.64,"askSize":349000,"bidPrice":12.62,"bidSize":261000,"shortable":3,"etf":0,"ttmEps":0.8343973585659243,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1497283200000,"adjPreClose":13.24,"adrRate":0,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":1.7545766922592159,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1714320000000,"strike":"17.50","timestamp":1713490682495,"price":0.009999999776482582,"volume":600,"amount":3000,"type":"*"},{"symbol":"WXB.HK","call":true,"expireDate":1714320000000,"strike":"17.50","timestamp":1713490685689,"price":0.009999999776482582,"volume":400,"amount":2000,"type":"*"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK"},"requestUrl":"/m/hq/s/02269/tweets","defaultTab":"tweets","newsList":[{"id":"2428610735","title":"易方达张坤最新持仓动向曝光:减持药明生物,买入山西汾酒,还买了光刻机巨头","url":"https://stock-news.laohu8.com/highlight/detail?id=2428610735","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428610735?lang=zh_cn&edition=full","pubTime":"2024-04-20 12:37","pubTimestamp":1713587848,"startTime":"0","endTime":"0","summary":"减持药明生物,买入山西汾酒Wind数据显示,截至一季度末,易方达张坤管理的4只基金,累计规模约为647亿元,相比于去年底的约655亿元,有小幅下降。此外,股价持续下跌的药明生物,已经退出了前十大,取而代之的是山西汾酒。再看易方达优质企业三年持有期混合,一季度同样也减持了招商银行、中国海洋石油、五粮液等个股,药明生物同样也是退出前十大,新进前十大也是山西汾酒。张坤进一步表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420123937879864c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420123937879864c4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428654532","title":"药明生物(02269.HK)4月19日耗资1992万港元回购157万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428654532","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428654532?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:16","pubTimestamp":1713532610,"startTime":"0","endTime":"0","summary":"格隆汇4月19日丨药明生物(02269.HK)公告,4月19日耗资1992万港元回购157万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192116558b3b3f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192116558b3b3f73&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428511226","title":"药明生物(02269)4月19日斥资1992.04万港元回购157万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428511226","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428511226?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:16","pubTimestamp":1713532583,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明生物(02269)发布公告,于2024年4月19日该公司斥资1992.04万港元回购157万股,回购价格为每股12.62-12.80港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105827.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428274682","title":"药明生物04月19日遭主力抛售7175万元 环比增加2149.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428274682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428274682?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514509,"startTime":"0","endTime":"0","summary":"04月19日, 药明生物股价跌4.68%,报收12.62元,成交金额6.27亿元,换手率1.16%,振幅4.98%,量比1.75。药明生物今日主力资金净流出7175万元,连续7日净流出,上一交易日主力净流出319万元,今日环比增加2149.22%。该股近5个交易日下跌9.78%,主力资金累计净流出1.18亿元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出8095万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615178b3a1c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191615178b3a1c0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428882386","title":"药明生物(02269)出现大手卖出54.95万股,成交价$12.66,涉资695.667万","url":"https://stock-news.laohu8.com/highlight/detail?id=2428882386","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428882386?lang=zh_cn&edition=full","pubTime":"2024-04-19 14:00","pubTimestamp":1713506400,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午02:00出现大手卖出,成交量为54.95万,成交价为港币$12.66,涉资695.667万。至目前为止,股价跌4.381%,今日最高价为$13.16,而最低价为$12.5,总成交量为3.45千万股,总成交金额港币$4.398亿。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404193299/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428701415","title":"医药外包概念集体走低 泰格医药(03347)跌超7% 机构称国内医药投融资仍阶段性承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2428701415","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2428701415?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:49","pubTimestamp":1713494972,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股持续走低,泰格医药(03347)跌7.62%,康龙化成(03759)跌5.17%,药明生物(02269)、药明康德(02359)均跌超4%。开源证券研报指出,2024年1-3月中国医疗健康产业融资额合计约138.79亿元,同比下滑22.80%;中国医疗健康产业融资事件数在2023Q4阶段性增加后,于2024年回落,2024年1-3月合计约270个,同比下滑14.83%,国内医疗健康领域投融资整体仍处于承压阶段。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935379","is_publish_highlight":false,"gpt_icon":0},{"id":"2428808128","title":"药明生物(02269.HK)回购151万股 涉资1,989万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428808128","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428808128?lang=zh_cn&edition=full","pubTime":"2024-04-17 01:10","pubTimestamp":1713287400,"startTime":"0","endTime":"0","summary":"药明生物(02269.HK) 报表披露,4月16日,于联交所回购151万股,每股作价介乎12.9-13.42元,总代价约1,989万元。自普通决议案通过至今,公司累计回购9,158.7万股,占股本2.15579%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-16 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190319113802916_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190319113802916_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1342759/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2427790826","title":"药明生物(02269)4月16日斥资1989.32万港元回购151万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427790826","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427790826?lang=zh_cn&edition=full","pubTime":"2024-04-16 20:22","pubTimestamp":1713270158,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明生物(02269)发布公告,于2024年4月16日,该公司斥资1989.32万港元回购151万股,每股回购价为12.9-13.42港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103522.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427897965","title":"药明生物(02269)股价下跌5.007%,现价港币$12.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2427897965","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427897965?lang=zh_cn&edition=full","pubTime":"2024-04-16 14:05","pubTimestamp":1713247500,"startTime":"0","endTime":"0","summary":"[下跌股]药明生物(02269) 股价在下午02:05比前收市价下跌5.007%,现股价为港币$12.9。至目前为止,今日最高价为$13.54,而最低价为$12.9。总成交量为2.22千万股,总成交金额为港币$2.95亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404162820/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427632978","title":"药明生物(02269)出现大手卖出51.25万股,成交价$13.38,涉资685.725万","url":"https://stock-news.laohu8.com/highlight/detail?id=2427632978","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427632978?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:50","pubTimestamp":1713232200,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在上午09:50出现大手卖出,成交量为51.25万,成交价为港币$13.38,涉资685.725万。至目前为止,股价跌1.325%,今日最高价为$13.54,而最低价为$13.32,总成交量为484.656万股,总成交金额港币$6.506千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404161184/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427102552","title":"药明生物04月15日遭主力抛售1862万元 环比增加160.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427102552","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427102552?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:15","pubTimestamp":1713168928,"startTime":"0","endTime":"0","summary":"04月15日, 药明生物股价跌2.30%,报收13.58元,成交金额2.72亿元,换手率0.47%,振幅4.32%,量比0.52。药明生物今日主力资金净流出1862万元,连续3日净流出,上一交易日主力净流出714万元,今日环比增加160.78%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为57.14%,平均跌幅为3.32%。该股近5个交易日下跌3.55%,主力资金累计净流出2550万元;近20日主力资金累计净流出9978万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151615488b2526be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151615488b2526be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427056047","title":"无锡药明生物技术股份有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2427056047","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427056047?lang=zh_cn&edition=full","pubTime":"2024-04-15 15:21","pubTimestamp":1713165703,"startTime":"0","endTime":"0","summary":"4月15日,据CDE官网消息,兆科(广州)肿瘤药物有限公司、无锡药明生物技术股份有限公司联合申请药品“索卡佐利单抗注射液”,获得临床试验默示许可,受理号CXSL2400091。公示信息显示,药品“索卡佐利单抗注射液”适应症:持续或复发或转移性宫颈癌的一线治疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151521478b24ed9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151521478b24ed9b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426217388","title":"药明生物4月11日斥资1990.2万港元回购141.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426217388","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426217388?lang=zh_cn&edition=full","pubTime":"2024-04-12 07:42","pubTimestamp":1712878940,"startTime":"0","endTime":"0","summary":"药明生物(02269)发布公告,于2024年4月11日,该公司斥资1990.2万港元回购141.5万股,每股回购价为13.98-14.16港元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzh7378020.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzh7378020.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426296533","title":"更新版 1-富士胶片将在北卡罗来纳州投资 12 亿美元扩建生物制药工厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2426296533","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426296533?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:07","pubTimestamp":1712858843,"startTime":"0","endTime":"0","summary":" 路透社东京4月11日 - 日本富士胶片 公司周四表示,将投资12亿美元扩建其在北卡罗来纳州的工厂,这是该公司在美国和欧洲拓展生物制药合同生产业务计划的一部分。该公司在一份声明 中说,到 2031 年,这项投资将为富士胶片 Diosynth 生物技术公司位于北卡罗来纳州霍利斯普林斯的工厂增加 680 个工作岗位。日经商业日报》周五报道称,富士胶片计划到2028年在其全球生物制药生产基地投资总计45亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426264371","title":"药明生物(02269.HK)回购141.5万股 涉资1,990万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426264371","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426264371?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:38","pubTimestamp":1712849880,"startTime":"0","endTime":"0","summary":"药明生物(02269.HK) 报表披露,4月11日,于联交所回购141.5万股,每股作价介乎13.98-14.16元,总代价约1,990万元。自普通决议案通过至今,公司累计回购9,007.7万股,占股本2.12025%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-11 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190319113802916_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190319113802916_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1341711/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426265419","title":"药明生物(02269.HK)4月11日耗资1990.2万港元回购141.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426265419","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2426265419?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:32","pubTimestamp":1712845936,"startTime":"0","endTime":"0","summary":"格隆汇4月11日丨药明生物(02269.HK)公告,4月11日耗资1990.2万港元回购141.5万股。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-11/doc-inarnqvn8782559.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-11/doc-inarnqvn8782559.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426263540","title":"药明生物(02269)4月11日斥资1990.2万港元回购141.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426263540","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426263540?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:07","pubTimestamp":1712844465,"startTime":"0","endTime":"0","summary":"药明生物(02269)发布公告,于2024年4月11日,该公司斥资1990.2万港...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_31.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101419.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426400272","title":"药明生物(02269)下跌2.09%,报14.04元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426400272","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426400272?lang=zh_cn&edition=full","pubTime":"2024-04-11 13:36","pubTimestamp":1712813808,"startTime":"0","endTime":"0","summary":"4月11日,药明生物(02269)盘中下跌2.09%,截至13:36,报14.04元/股,成交3.0亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/11133640196239.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426455535","title":"药明生物(02269)出现大手买入44.2万股,成交价$14.3,涉资632.06万","url":"https://stock-news.laohu8.com/highlight/detail?id=2426455535","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426455535?lang=zh_cn&edition=full","pubTime":"2024-04-10 15:58","pubTimestamp":1712735880,"startTime":"0","endTime":"0","summary":"[大手成交]药明生物(02269)在下午03:58出现大手买入,成交量为44.2万,成交价为港币$14.3,涉资632.06万。至目前为止,股价跌0.833%,今日最高价为$15.0,而最低价为$14.14,总成交量为3.995千万股,总成交金额港币$5.82亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404103894/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426107711","title":"药明生物(02269)上涨2.08%,报14.7元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426107711","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426107711?lang=zh_cn&edition=full","pubTime":"2024-04-10 10:46","pubTimestamp":1712717186,"startTime":"0","endTime":"0","summary":"4月10日,药明生物(02269)盘中上涨2.08%,截至10:46,报14.7元/股,成交3.13亿元。药明生物技术有限公司是全球领先的生物制剂服务供应商,提供全面、综合及高度定制的服务,包括从发现、开发到生产生物制剂的全过程。公司在2016年在中国生物制剂研发市场占有48%的市场份额,已与全球20大制药公司中的12家建立合作关系。截至2023年年报,药明生物营业总收入170.34亿元、净利润34.0亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10104640177185.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":-0.0921},{"period":"1month","weight":-0.0934},{"period":"3month","weight":-0.5549},{"period":"6month","weight":-0.7262},{"period":"1year","weight":-0.758},{"period":"ytd","weight":-0.5736}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明生物技术有限公司是一家主要提供生物制剂发现、开发及生产服务的投资控股公司。该公司的技术平台包括WuXiBody TM双特异抗体技术平台及抗体偶联药物(ADC)技术平台等。其引入多个新项目至研发管线。该公司有疫苗生产基地,为客户生产疫苗以供应全球市场。该公司于中国市场及北美,欧洲和其他海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.035713},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.034807},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.00624},{"month":4,"riseRate":0.428571,"avgChangeRate":0.010542},{"month":5,"riseRate":0.5,"avgChangeRate":0.018035},{"month":6,"riseRate":0.5,"avgChangeRate":0.075451},{"month":7,"riseRate":0.714286,"avgChangeRate":0.068513},{"month":8,"riseRate":0.571429,"avgChangeRate":0.03818},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.041003},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.017109},{"month":11,"riseRate":0.571429,"avgChangeRate":0.064498},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.013887}],"exchange":"SEHK","name":"药明生物","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物,02269,药明生物股票,药明生物股票老虎,药明生物股票老虎国际,药明生物行情,药明生物股票行情,药明生物股价,药明生物股市,药明生物股票价格,药明生物股票交易,药明生物股票购买,药明生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物(02269)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物(02269)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}